Pathogenesis of infantile haemangioma: New molecular and cellular insights

Expert Reviews in Molecular Medicine

Volumn 9, Issue 32, 2007, Pages 1-19

  Ritter, Matthew R ^a   Butschek, Ross A ^a   Friedlander, Martin ^a   Friedlander, Sheila F ^a,b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA INTEGRIN; ALPHA INTERFERON; ALPHA5 INTEGRIN; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; BASIC FIBROBLAST GROWTH FACTOR; BECAPLERMIN; BETA INTERFERON; CLUSTERIN; CORTICOSTEROID; CYTOCHROME B; CYTOKERATIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ESTRADIOL; FIBROBLAST GROWTH FACTOR RECEPTOR 4; HUMAN PLACENTA LACTOGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMIQUIMOD; INDOLEAMINE 2,3 DIOXYGENASE; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; SELECTIN; SOMATOMEDIN C; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNINDEXED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 3; VINCRISTINE; ZINC OXIDE;

ALTERNATIVE HYPOTHESIS; ANGIOGENESIS; ANIMAL MODEL; ARTICLE; BEHAVIOR; CELL CYCLE REGULATION; CLINICAL FEATURE; CONGENITAL BLOOD VESSEL MALFORMATION; DEVELOPMENT; DISEASE MODEL; ENDOTHELIUM CELL; ETIOLOGY; GROWTH REGULATION; GROWTH RETARDATION; HEMANGIOMA; HUMAN; INFANCY; INFANT DISEASE; INFANTILE HEMANGIOMA; INFECTION; INVOLUTION; LIFE CYCLE; NEUROLOGICAL COMPLICATION; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRECURSOR; PRIORITY JOURNAL; SIDE EFFECT; SPASTIC DIPLEGIA; THERAPY; TUMOR GROWTH; VASCULAR LESION; VASCULAR TUMOR; ANIMAL; BIOLOGICAL MODEL; CELL HYPOXIA; HEMATOPOIETIC STEM CELL; INFANT; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; PLACENTA; REVIEW;

ANIMALS; CELL HYPOXIA; HEMANGIOMA; HEMATOPOIETIC STEM CELLS; HUMANS; INFANT; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PATHOLOGIC; PLACENTA;

EID: 38449085499     PISSN: 14623994     EISSN: 14623994     Source Type: Journal    
DOI: 10.1017/S146239940700052X     Document Type: Article

References (108)

1. Mulliken, J.B. and Glowacki, J. (1982) Hemangiomas and vascular malformations in infants and children: A classification based on endothelial characteristics. Plast Reconstr Surg 69, 412-422
2. Finn, M.C., Glowacki, J. and Mulliken, J.B. (1983) Congenital vascular lesions: Clinical application of a new classification. J Pediatr Surg 18, 894-900
3. Amir, J. et al. (1986) Strawberry hemangioma in preterm infants. Pediatr Dermatol 3, 331-332
4. Haggstrom, A.N. et al. (2007) Prospective study of infantile hemangiomas: Demographic, prenatal, and perinatal characteristics. J Pediatr 150, 291-294
5. Haggstrom, A.N. et al. (2006) Prospective study of infantile hemangiomas: Clinical characteristics predicting complications and treatment. Pediatrics 118, 882-887
6. Orlow, ST, Isakoff, M.S. and Blei, F. (1997) Increased risk of symptomatic hemangiomas of the airway in association with cutaneous hemangiomas in a "beard" distribution. J Pediatr 131, 643-646
7. Chiller, K.G., Passaro, D, and Frieden, I.J. (2002) Hemangiomas of infancy: Clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex. Arch Dermatol 138, 1567-1576
8. Warner, M. et al. (2003) The nonrandom distribution of facial hemangiomas. Arch Dermatol 139, 869-875
9. Haggstrom, A.N. et al. (2006) Patterns of infantile hemangiomas: New clues to hemangioma pathogenesis and embryonic facial development. Pediatrics 117, 698-703
10. Frieden, I.J., Reese, V. and Cohen, D. (1996) PHACE syndrome. The association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities. Arch Dermatol 132, 307-311
11. Metry, D.W et al. (2006) A prospective study of PHACE syndrome in infantile hemangiomas: Demographic features, clinical findings, and complications. Am J Med Genet A 140, 975-986
12. North, P.E. et al. (2006) Vascular tumors of infancy and childhood: beyond capillary hemangioma. Cardiovasc Pathol 15, 303-317
13. Bennett, M.L. et al. (2001) Oral corticosteroid use is effective for cutaneous hemangiomas: An evidence-based evaluation. Arch Dermatol 137, 1208-1213
14. Metz, B.J. et al. (2004) Response of ulcerated perineal hemangiomas of infancy to becaplermin gel, a recombinant human platelet-derived growth factor. Arch Dermatol 140, 867-870
15. Martinez, M.I. et al. (2002) Infantile hemangioma: Clinical resolution with 5% imiquimod cream. Arch Dermatol 138, 881-884
16. Welsh, O. et. al. (2004) Treatment of infantile hemangiomas with short-term application of imiquimod 5% cream. J Am Acad Dermatol 51, 639-642
17. Hazen, P.G. et al. (2005) Proliferating hemangioma of infancy successful treatment with topical 5% imiquimod cream. Pediatr Dermatol 22, 254-256
18. Tan S.T. et al. (2000) Cellular and extracellular markers of hemangioma. Plast Reconstr Surg 106, 529-538
19. Kraling, B.M. et al. (1996) E-selectin s present in proliferating endothelial cells in human hemangiomas. Am J Pathol 148, 1181-1191
20. Ritter, M.R. et al. (2002) Insulin-like growth factor 2 and potential regulators of hemangioma with and involution identified by large-scale expression analysis. Proc Natl Acad Sci U S A 99, 7455-7460
21. Bielenberg, D.R. et al. (1999) Progressive growth of infantile cutaneous hemangiomas is directly correlated with hyperplasia and angiogenesis of adjacent epidermis and inversely correlated with expression of the endogenous angiogenesis inhibitor, IFN-beta. Int J Oncol 14, 401-408
22. Takahashi, K. et al. (1994) Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest 93, 2357-2364
23. Chang, J. et al. (1999) Proliferative hemangiomas: Analysis of cytokine gene expression and angiogenesis. Plast Reconstr Surg 103, 1-9
24. Yu, Y. et al. (2001) Increased Tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells. Am J Pathol 159, 2271-2280
25. Carmeliet, P. (2005) Angiogenesis in life, disease and medicine. Nature 438, 932-936
26. Drake, C.J. and Fleming, P.A. (2000) Vasculogenesis in the day 6.5 to 9.5 mouse embryo. Blood 95, 1671-1679
27. Choi, K. et al. (1998) A common precursor for hematopoietic and endothelial cells. Development 125, 725-732
28. Ferrara, N. and Kerbel, R.S. (2005) Angiogenesis as a therapeutic target. Nature 438, 967-974
29. Friedlander, RE, Ritter, M.R. and Friedlander, M. (2005) Recent progress in our understanding of the pathogenesis of infantile hemangiomas. Lymphat Res Biol 3, 219-225
30. Bauland, C.G. et al. (2006) The pathogenesis of hemangiomas: A review. Plast Reconstr Surg 117, 29e-35e
31. Blei, F. et al. (1998) Familial segregation of hemangiomas and vascular malformations as an autosomal dominant trait. Arch Dermatol 134, 718-722
32. Walter, J.W. et al. (11999) Genetic mapping of a novel familial form of infantile hemangioma. Am J Med Genet 82, 77-83
33. Bischoff, J. (2002) Monoclonal expansion of endothelial cells in hemangioma: An intrinsic defect with extrinsic consequences? Trends Cardiovasc Med 12, 220-224
34. Allen, R.C. et al. (1992) Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 51, 1229-1239
35. Boye, E. et al. (2001) Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest 107, 745-752
36. Walter, J.W. et al. (2002) Somatic mutation of vascular endothehal growth factor receptors. in juvenile hemangioma. Genes Chromosomes Cancer 33, 295-303
37. Khan, Z.A. et al. (2006) Endothelial progenitor cells from infantile hemangioma and umbilical cord blood display unique cellular responses to endostatin. Blood 108, 915-921
38. Schmidt, A., Addicks, K. and Bloch, W. (2004) Opposite effects of endostatin on different endothelial cells. Cancer Biol Ther 3, 1162-1166; discussion 1167-1168
39. Li, Q. et al. (2003) Differential expression of CD146 in tissues and endothelial cells derived from infantile haemangioma and normal human skin. J Pathol 201, 296-302
40. Kaplan, P. et al. (1990) Malformations and minor anomalies in children whose mothers had prenatal diagnosis: Comparison between CVS and amniocentesis. Am J Med Genet 37, 366-370
41. Burton, B.K. et al. (1995) An increased incidence of haemangiomas in infants born following chorionic villus sampling (CVS). Prenat Diagn 15, 209-214
42. Powell, T.G. et al. (1987) Epidemiology of strawberry haemangioma in low birthweight infants. Br J Dermatol 116, 635-641
43. North, P.E. et al. (2001) A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol 137, 559-570
44. North, P.E., Waner, M. and Brodsky, M.C. (2002) Are infantile hemangiomas of placental origin? Ophthalmology 109, 633-634
45. Bree, A.F. et al. (2001) Iniantile hemangiomas: Speculation on placental trophoblastic, origin. Arch Dermatol 137, 573-577
46. Barnes, C.M. et al. (2005) Evidence by molecular profiling for a placental origin of infantile hemangioma. Proc Natl Acad Sci U S A 102, 19097-19102
47. Asahara, T. et al. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964-967
48. Yoder, M.C. et al. (2007) Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109, 1801-1809
49. Kleinman, M.E. et al. (2003) Increased circulating AC133+ CD34+ endothelial progenitor cells in children with hemangioma. Lymphat Res Biol, 1, 301-307
50. Peichev, M. et al. J2Q00) Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95, 952-958
51. Yu, Y. et al. (2004) Endothelial progenitor cells in infantile hemangioma. Blood 103, 1373-1375
52. Yu, Y. et al. (2006) Mesenchymal stem cells and adipogenesis in hemangioma involution. Stem Cells 24, 1605-1612
53. Ritter, M.R. et al. (2006) Myeloid cells in infantile hemangioma. Am J Pathol 168, 621-628
54. Fernandez Pujol, B. et al. (2000) Endothelial-like cells derived from human CD14 positive monocytes. Differentiation 65, 287-300
55. Havemann, K., Pujol, B.F. and AdamKiewicz, J. (2003) In vitro-transformation of monocytes and dendritic cells into endothelial like cells. Adv Exp Med Biol 522, 47-57
56. Bailey, A.S. et al. (2006) Myeloid lineage progenitors give rise to vascular endothelium. Proc Natl Acad Sci U S A 103, 13156-13161
57. Dadras, S.S. et al. (2004) Infantile hemangiomas are arrested in an early developmental vascular differentiation state. Mod Pathol 17, 1068-1079
58. Nguyen, VA. et al. (2006) Infantile hemangioma is a proliferation of LYVE-1-negative blood endothelial cells without lymphatic competence. Mod Pathol 19, 291-298
59. Hamlat, A. et al. (2005) Pathophysiology of capillary haemangioma growth after birth. Med Hypotheses 64, 1093-1096
60. Kleinman, M.E., Blei, E arid Gurtner, G.C. (2005) Circulating endothelial progenitor cells and vascular anomalies. Lymphat Res Biol 3, 234-239
61. Semenza, G.L. (1999) Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15, 551-578
62. Cejudo-Martin, P. and Johnson, R.S., (2005) A new notch in the HIF belt: how hypoxia impacts differentiation. Dev Cell 9, 575-576
63. Manalo, D.J. et al. (2005) Transcriptional regulation of vascular endothehal cell responses to hypoxia by HIF-1. Blood 105, 659-669
64. Feldser, D. et al. (1999) Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. Cancer Res 59, 3915-3918
65. Loike, J.D. et al. (1992) Hypoxia induces glucose transporter expression in endothelial cells. Am J Physiol 263, C326-333
66. Yu, Y et al. (2004) Genomic imprinting of IGF2 is maintained in infantile hemangioma despite its high level of expression. Mol Med 10, 117-123
67. Burns, J.L., Jackson, D.A. and Hassan, A.B. (2001) A view through the clouds of imprinting. Faseb J 15, 1694-1703
68. Ogawa, O. et al. (1993) Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour Nature 362, 749-751
69. Constancia, M. et al. (200-2) Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature 417, 945-948
70. Ceradini, D.J. et al. (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10, 858-864
71. Ogino, S. and Redline, R.W. (2000) Villous capillary lesions of the placenta: Distinctions between chorangioma, chorangiomatosis, and chorangiosis. Hum Pathol 31, 945-954
72. Reshetnikova, O.S. et al. (1996) Increased incidence of placental chorioangioma in high-altitude pregnancies: Hypobaric hypoxia as a possible etiologic factor. Am J Obstet Gynecol 174, 557-561
73. Bakaris, S. et al. (2004) Case of large placental chorioangioma associated with diffuse neonatal hemangiomatosis. Pediatr Dev Pathol 7, 258-261
74. Metry D.W. and Hebert, A.A. (2000) Benign cutaneous vascular tumors of infancy: When to worry what to do. Arch Dermatol 136, 905-914
75. Iwata, J. et al. (1996) High frequency of apoptosis in infantile capillary haemangioma. J Pathol 179, 403-408
76. Mancini, A.J. and Smoller, B.R. (1996) Proliferation and apoptosis within juvenile capillary hemangiomas. Am J Dermatopathol 18, 505-514
77. Razon, M.J. et al. (1998) Increased apoptosis coincides with onset of involution in infantile hemangioma. Microcirculation 5, 189-195
78. Halperin, R. et al. (2000) Placental apoptosis in normal and abnormal pregnancies. Gynecol Obstet Invest 50, 84-87
79. Smith, S.C. et al. (2000) Apoptosis is a rare event in first-trimester placental tissue. Am J Obstet Gynecol 183, 697-699
80. Ritter, M.R. et al. (2003) Identifying potential regulators of infantile hemangioma progression through large-scale expression analysis: A possible role for the immune system and indoleamine 2,3 dioxygenase (IDO) during involution Lymphat Res Biol 1, 291-299
81. North, RE. et al. (20.04) High expression of indoleamine 2,3 deoxygenase in infantile hemangioma: Evidence for immune tolerance. Mod Pathol 17(S1), 97A (Abstract)
82. Mellor, A.L. et al. (2001) Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol 2, 64-68
83. Takikawa, O. et al. (1986) Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase. J Biol Chem 261, 3648-3653
84. Frumento, G. et al. (2002) Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med 196, 459-468
85. Glowacki, J. and Mulliken, J.B. (1982) Mast cells in hemangiomas and vascular malformations. Pediatrics 70, 48-51
86. Tan, S.T. et al. (2004) Mast cells and hemangioma. Plast Reconstr Surg 113, 999-1011
87. Hasan, Q. et al. (2000) Clusterin/apoJ expression during the development of hemangioma. Hum Pathol 31, 691-697
88. Meininger, C.J. and Zetter, B.R. (1992) Mast cells and angiogenesis. Semin Cancer Biol 3, 73-79
89. Obeso, J., Weber, J. and Auerbach, R. (1990) A hemangioendothelioma-derived cell line: Its use as a model for the study of endothelial cell biology. Lab Invest 63, 259-269
90. Bautch, V.L. et al. (1987) Endoithelial cell tumors develop in transgenic mice carrying polyoma virus middle T oncogene. Cell 51, 529-537
91. Tan S.T. et al. (2000) A novel in vitro human model of hemangioma. Mod Pathol 13, 92-99
92. North, P.E. et al. (2003) Ex vivo hemangiogenesis in fibrin gels: A morphological and immunohistochemical analysis. Lab Invest 83, 18A (Abstract)
93. Frieden, I.J. et al. (2005) Infantile hemangiomas: Current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7-9, 2005, Bethesda, Maryland, USA. Pediatr Dermatol 22, 383-406
94. Peng, Q. et al. (2005) The establishment of the hemangioma model in nude mouse. J Pediatr Surg 40, 1167-1172
95. Ezekowitz, R.A., Mulliken, J.B. and Folkman, J. (1992) Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 326, 1456-1463
96. Chang, E. et al. (1997) Successful treatment of infantile hemangiomas with interferon-alpha-2b. J Pediatr Hematol Oncol 19, 237-244
97. Barlow, C.F. et al. (1998) Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy. J Pediatr 132, 527-530
98. Greinwald, J.H., Jr. et al. (1999) An update on the treatment of hemangiomas in children with interferon alfa-2a. Arch Otolaryngol Head Neck Surg 125, 21-27
99. Boon, L.M., MacDonald, D.M. and Mulliken, J.B. (1999) Complications of systemic corticosteroid therapy for problematic hemangioma. Plast Reconstr Surg 104, 1616-1623
100. Huang, S.A. et al. (2000) Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med 343, 185-189
101. Pittman, K.M. et al. (2006) No evidence for maternal-fetal microchimerism in infantile hemangioma: A molecular genetic investigation. J Invest Dermatol 126, 2533-2538
102. Regnier, S. et al. (2007) Endothelial cells in infantile haemangiomas originate from the child and not from the mother (a fluorescence in situ hybridization-based study). Br J Dermatol 157, 158-160
103. Sasaki, G.H., Pang, C.Y. and Wittliff, J.L. (1984) Pathogenesis and treatment of infant skin strawberry hemangiomas: Clinical and in vitro studies of hormonal effects. Plast Reconstr Surg 73, 359-370
104. Lui, W, et al. (1997) Sex hormone receptors of hemangiomas in children. Chin Med J (Engl) 110, 349-351
105. Malamitsi-Puchner, A. et al. (2000) Changes in serum levels of vascular endothelial growth factor in males and females throughout life. J Soc Gynecol Investig 7, 309-312
106. Nguyen, V.A. et al. (2004) Infantile hemangioma is a proliferation of beta 4-negative endothelial cells adjacent to HLA-DR-positive cells with dendritic cell morphology. Hum Pathol 35, 739-744
107. Hasan, Q. et al. (2001) Altered mitochondrial cytochrome b gene expression during the regression of hemangioma. Plast Reconstr Surg 108, 1471-1476; discussion 1477-1479
108. Hand, J.L. and Frieden, I.J. (2002) Vascular birthmarks of infancy: resolving nosologic confusion. Am J Med Genet 108; 257-264